Clinical significances of liver fibrotic markers in patients with cholangiocarcinoma after radical resections
Atsushi Nanashima
, Masahide Hiyoshi, Naoya Imamura, Takeomi Hamada, Yuki Tsuchimochi, Takashi Wada, Ikko Shimizu, Takahiro Ochiai
Division of Hepato-Biliary-Pancreas Surgery, Department of Surgery, Miyazaki University Faculty of Medicine, Miyazaki, Japan
Abstract
Objective: We examined the relation between several fibrotic markers reflecting liver parenchymal injury and conventional liver function or surgical outcomes in 67 patients with cholangiocarcinoma who underwent biliary drainage for obstructive jaundice followed by surgical resection.
Material and Methods: We examined conventional clinicopathological factors, six hepatic fibrosis parameters, including platelet count, hyaluronic acid, Mac-2 binding protein glycosylation isomer (M2BPGi), type IV collagen 7S, aspartate aminotransferase-to-platelet ratio index (APRI), and FIB-4 index before hepatectomy, and surgical outcomes or long-term prognosis.
Results: Obstructive jaundice was observed in 57% of the patients, a history of biliary diseases in 7.5%, and chronic hepatic injuries in 17.9%. M2BPGi was significantly higher in patients with obstructive jaundice as the primary sign (p< 0.05), the FIB-4 index was significantly correlated with patient age (p< 0.01), and serum hyaluronic acid and T4C7 levels were significantly increased in distal cholangiocarcinoma (CC). No markers were associated with the histological hepatic fibrotic index, tumor-related factors, or postoperative morbidities. Tumor relapse was observed in 37% of patients, and cancer-related death was observed in 25%. A higher FIB-4 index was significantly associated with shorter cancer-free survival (p< 0.05). Cox multivariate analysis showed that bilirubin levels, poor histological cancer differentiation, and absence of fibrotic markers were associated with cancer-free, cancer-specific overall, and overall survival.
Conclusion: Although a sufficient relation exists between these markers and elastographic or histological fibrotic indexes, the clinical significance of measuring conventional fibrotic markers might no longer be necessary in future studies.
Keywords: Cholangiocarcinoma, obstructive jaundice, fibrotic markers, liver dysfunction, surgical outcomes, patient prognosis
Cite this article as: Nanashima A, Hiyoshi M, Imamura N, Hamada T, Tsuchimochi Y, Wada T, et al. Clinical significances of liver fibrotic markers in patients with cholangiocarcinoma after radical resections. Turk J Surg 2024; 40 (4): 283-295.